SUBSEQUENT EVENTS (Details Narrative) - USD ($) |
1 Months Ended | 9 Months Ended |
|---|---|---|
Aug. 25, 2020 |
Sep. 30, 2020 |
|
| Value of shares converted | $ 10,000 | |
| Common Stock [Member] | ||
| Number of shares converted | 27,002 | |
| Value of shares converted | $ 3 | |
| Share Exchange Agreement [Member] | Sigyn Therapeutics, Inc [Member] | ||
| Percentage of acquisition ownership interest | 100.00% | |
| Percentage of common stock outstanding | 75.00% | |
| Acquisition date | Oct. 19, 2020 | |
| Share Exchange Agreement [Member] | Sigyn Therapeutics, Inc [Member] | Common Stock [Member] | ||
| Number of shares converted | 7,907,351 | |
| Value of shares converted | $ 3,429,516 |
| X | ||||||||||
- Definition Percentage of common stock outstanding. No definition available.
|
| X | ||||||||||
- Definition Date when the business acquisition agreement was executed, in CCYY-MM-DD format. No definition available.
|
| X | ||||||||||
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|